You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MERS-CoV

Showing 1 - 25 of 2,957
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Jordan, Kenya, Lebanon (INO-4700, Placebo, CELLECTRA™ 2000)

Completed
  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  • Irbid, Jordan
  • +5 more
Jan 27, 2023

MERS (Middle East Respiratory Syndrome) Trial in Oxford (ChAdOx1 MERS)

Terminated
  • MERS (Middle East Respiratory Syndrome)
  • ChAdOx1 MERS
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Oct 12, 2021

Middle East Respiratory Syndrome Coronavirus Trial in Riyadh (ChAdOx1 MERS)

Completed
  • Middle East Respiratory Syndrome Coronavirus
  • ChAdOx1 MERS
  • Riyadh, Saudi Arabia
    King Abdulaziz Medical City, National Guard Health Affairs
Nov 29, 2020

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Riyadh (Combination of Lopinavir /Ritonavir and Interferon

Completed
  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  • Combination of Lopinavir /Ritonavir and Interferon beta-1b
  • Placebo
  • Riyadh, Saudi Arabia
  • +1 more
May 18, 2020

COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

Recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901a
  • Halifax, Nova Scotia, Canada
  • +6 more
Nov 16, 2022

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022

Corona Virus Infection, Middle East Respiratory Syndrome (MERS), Acute Respiratory Distress Syndrome Trial in Cairo (Lactoferrin

Not yet recruiting
  • Corona Virus Infection
  • +5 more
  • Lactoferrin (Apolactoferrin)
  • Placebo of excipient(s) will be administered
  • Cairo, Giza, Egypt
  • +3 more
Nov 12, 2021

Bronchoalveolar Lavage Trial in Mansoura (Bronchoalveolar Lavage)

Completed
  • Bronchoalveolar Lavage
  • Bronchoalveolar Lavage
  • Mansoura, Egypt
    Mohamed AbdElmoniem
Aug 31, 2023

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Recruiting
  • Influenza
  • +2 more
    • San Diego, California
    • +62 more
    Mar 28, 2022

    ABO Blood Group Type Association With COVID-19 Severity

    Completed
    • COVID-19
    • +4 more
    • No Intervention
    • Colton, California
      Arrowhead Regional Medical Center
    May 15, 2023

    Infection Tracking in Travellers. The Project Aims to Identify

    Not yet recruiting
    • Travel-Related Illness
    • +8 more
    • Observational study
    • Zürich, Switzerland
      Epidemiology, Biostatistics and Prevention Institute at the Univ
    Dec 16, 2020

    Monitoring the IgG/IgM Antibodies in COVID-19 Patients

    Completed
    • COVID-19 Infections
    • Serodiagnosis of IgG and IgM
    • Bhakkar, Punjab, Pakistan
    • +1 more
    Jul 18, 2022

    SARS-CoV 2 Trial in Paris (Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration)

    Recruiting
    • SARS-CoV 2
    • Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration
    • Paris, France
      Intensive Care Unit and Respiratory division ; Groupe hospitalie
    Jun 18, 2021

    MERS (Middle East Respiratory Syndrome) Trial in Hamburg, Rotterdam (MVA-MERS-S_DF1 - Low Dose, MVA-MERS-S_DF1 - High Dose,

    Recruiting
    • MERS (Middle East Respiratory Syndrome)
    • MVA-MERS-S_DF1 - Low Dose
    • +2 more
    • Hamburg, Germany
    • +1 more
    Aug 1, 2021

    MERS (Middle East Respiratory Syndrome), MERS Trial in Sankt-Peterburg (BVRS-GamVac, )

    Recruiting
    • MERS (Middle East Respiratory Syndrome)
    • MERS
    • BVRS-GamVac
    • placebo
    • Sankt-Peterburg, Russian Federation
      Research Institute of Influenza
    Jan 13, 2021

    MERS (Middle East Respiratory Syndrome), MERS Trial in Sankt-Peterburg (BVRS-GamVac-Combi, )

    Recruiting
    • MERS (Middle East Respiratory Syndrome)
    • MERS
    • Sankt-Peterburg, Russian Federation
      ECO-Safety
    Jan 13, 2021

    Coronavirus Infection, COVID Trial in Adelaide (COVID19 vaccine, Saline)

    Completed
    • Coronavirus Infection
    • COVID
    • COVID19 vaccine
    • Saline
    • Adelaide, South Australia, Australia
      PARC,
    Feb 12, 2022

    Obstetric and Perinatal Outcomes of Women With COVID-19

    Completed
    • Pregnant Women
    • Examine the impact of COVID-19 during pregnancy
    • Marseille, Paca, France
      Assistance Publique Hôpitaux de Marseille
    Feb 9, 2022

    COVID-19 Trial in New Taipei City (Covid19 Vaccination dose)

    Recruiting
    • COVID-19
    • Covid19 Vaccination dose
    • New Taipei City, Taiwan
      TuCheng Hospital
    Apr 24, 2023

    Clinical Characteristics and Outcomes of Pediatric COVID-19

    Completed
    • COVID-19
    • +4 more
    • Exposure (not intervention) - SARS-CoV-2 infection
    • Calgary, Alberta, Canada
      University of Calgary/Alberta Children's Hospital
    May 16, 2022

    Covid19, SARS-CoV Infection Trial in Hershey, State College (Shampoo and saline, Saline and Listerine, Shampoo and Listerine)

    Recruiting
    • Covid19
    • SARS-CoV Infection
    • Shampoo and saline
    • +3 more
    • Hershey, Pennsylvania
    • +1 more
    Aug 25, 2022

    Corona Virus Infection Trial in Cypress (Placebo, REGN3048, REGN3051)

    Completed
    • Corona Virus Infection
    • Placebo
    • +2 more
    • Cypress, California
      WCCT Global Cypress Clinical Pharmacology Unit
    Jan 31, 2019

    Covid-19; SARS-Cov2 Trial (Blood sampling, Nasal Brushing)

    Not yet recruiting
    • Covid-19; SARS-Cov2
    • Blood sampling
    • Nasal Brushing
    • (no location specified)
    Oct 24, 2022

    COVID-19; Isolation of Neutralizing Antibodies for Therapeutics

    Active, not recruiting
    • SARS-CoV 2
    • Blood sampling
    • Grenoble, France
      UniversityGrenobleHospital
    Mar 24, 2022

    COVID-19 Pandemic Trial in Changsha (FB2001 for inhalation, FB2001 for inhalation )

    Completed
    • COVID-19 Pandemic
    • FB2001 for inhalation
    • FB2001 for inhalation placebo
    • Changsha, China
      The Third Hospital of Changsha
    Jan 9, 2023